Sasidharan Leelakumari Harikumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sasidharan Leelakumari Harikumar has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Geeta Aggarwal
Department of Pharmaceutics, Rayat and Bahra Institute of Pharmacy, Sahauran, Mohali, Punjab, India
6 shared publications Geeta Aggarwal
Rayat and Bahra Institute of Pharmacy, Sahauran, District Mohali, Punjab -140104, India
2 shared publicationsSanju Dhawan
2 shared publicationsA. P. Singh
Research and Development, I.K. Gujral Punjab Technical University, Jalandhar, India
1 shared publication- Abdul Basit Wani
Department of Chemistry, University of Kashmir, Srinagar, 190006, Jammu and Kashmir, India
1 shared publication - Abhishek Sharma
Department of Pharmaceutics, University Institute of Pharma Sciences, Chandigarh University, Mohali, India
1 shared publication
Latest Publications
- Open Access
- 22 March 2021
- Published by Akshantala Enterprises Private Limited in Journal of Evolution of Medical and Dental Sciences
- Vol. 10  (12) , 861-865
Profile of Transfusion Transmitted Infections – A Study among Blood Donors
BACKGROUND Transfusion of blood and blood products is an essential component of patient care in various health care settings. Blood is collected from non-remunerated donors. Many infections can spread through the transfusion of blood and blood components. Testing of donor blood for infectious agents prior to transfusion of blood products increases blood safety. Mandatory testing of five transfusion transmitted infections is done prior to transfusion following manufacturer’s instructions and quality specifications. Prevalence study will help the blood transfusion services to select and implement the strategies effectively for blood safety. METHODS This is a descriptive study based on retrospective collection of data from available records. Donor results were recorded and maintained to ensure the traceability of specific donor. The data was collected from the blood donor records and registers pertaining to the 10 year period from 2007 to 2016. Samples seroreactive for human immunodeficiency virus (HIV) antibodies, hepatitis B, hepatitis C, malaria and syphilis were recorded and analysed. RESULTS A total of 1,73,027 donors donated blood during the ten-year period. Of these 1, 65,824 were males and 7203 were females. Male to female ratio was 23:1. Hepatitis B surface antigen (HBsAg) seroreactivity is the most common which came to about 419 in this 10-year period with a prevalence rate of 0.24 % or 24 reactive cases in every 10,000 donors. Prevalence rate of Hepatitis C and HIV infection was 0.09 % and 0.035 % respectively. Rapid plasma reagin (RPR) and malaria reactivity was 0.02 %. CONCLUSIONS As safe blood supply is an important strategy of blood transfusion services, newer diagnostic tools should be implemented nationwide to overcome the problems with the window period and to detect infections with variant strains. KEY WORDS Prevalence, Transfusion Transmitted Infections, HIV, Hepatitis B and Hepatitis C, Syphilis
- 22 March 2021
- Published by Akshantala Enterprises Private Limited in Journal of Evolution of Medical and Dental Sciences
- Vol. 10  (12) , 861-865
Open AccessProfile of Transfusion Transmitted Infections – A Study among Blood Donors
BACKGROUND Transfusion of blood and blood products is an essential component of patient care in various health care settings. Blood is collected from non-remunerated donors. Many infections can spread through the transfusion of blood and blood components. Testing of donor blood for infectious agents prior to transfusion of blood products increases blood safety. Mandatory testing of five transfusion transmitted infections is done prior to transfusion following manufacturer’s instructions and quality specifications. Prevalence study will help the blood transfusion services to select and implement the strategies effectively for blood safety. METHODS This is a descriptive study based on retrospective collection of data from available records. Donor results were recorded and maintained to ensure the traceability of specific donor. The data was collected from the blood donor records and registers pertaining to the 10 year period from 2007 to 2016. Samples seroreactive for human immunodeficiency virus (HIV) antibodies, hepatitis B, hepatitis C, malaria and syphilis were recorded and analysed. RESULTS A total of 1,73,027 donors donated blood during the ten-year period. Of these 1, 65,824 were males and 7203 were females. Male to female ratio was 23:1. Hepatitis B surface antigen (HBsAg) seroreactivity is the most common which came to about 419 in this 10-year period with a prevalence rate of 0.24 % or 24 reactive cases in every 10,000 donors. Prevalence rate of Hepatitis C and HIV infection was 0.09 % and 0.035 % respectively. Rapid plasma reagin (RPR) and malaria reactivity was 0.02 %. CONCLUSIONS As safe blood supply is an important strategy of blood transfusion services, newer diagnostic tools should be implemented nationwide to overcome the problems with the window period and to detect infections with variant strains. KEY WORDS Prevalence, Transfusion Transmitted Infections, HIV, Hepatitis B and Hepatitis C, Syphilis
- Top Cited PapersOpen Access
- 15 October 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17  (20) , 7519
Herbicide Glyphosate: Toxicity and Microbial Degradation
Glyphosate is a non-specific organophosphate pesticide, which finds widespread application in shielding crops against the weeds. Its high solubility in hydrophilic solvents, especially water and high mobility allows the rapid leaching of the glyphosate into the soil leading to contamination of groundwater and accumulation into the plant tissues, therefore intricating the elimination of the herbicides. Despite the widespread application, only a few percentages of the total applied glyphosate serve the actual purpose, dispensing the rest in the environment, thus resulting in reduced crop yields, low quality agricultural products, deteriorating soil fertility, contributing to water pollution, and consequently threatening human and animal life. This review gives an insight into the toxicological effects of the herbicide glyphosate and current approaches to track and identify trace amounts of this agrochemical along with its biodegradability and possible remediating strategies. Efforts have also been made to summarize the biodegradation mechanisms and catabolic enzymes involved in glyphosate metabolism.
- 15 October 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17  (20) , 7519
Top Cited PapersOpen AccessHerbicide Glyphosate: Toxicity and Microbial Degradation
Glyphosate is a non-specific organophosphate pesticide, which finds widespread application in shielding crops against the weeds. Its high solubility in hydrophilic solvents, especially water and high mobility allows the rapid leaching of the glyphosate into the soil leading to contamination of groundwater and accumulation into the plant tissues, therefore intricating the elimination of the herbicides. Despite the widespread application, only a few percentages of the total applied glyphosate serve the actual purpose, dispensing the rest in the environment, thus resulting in reduced crop yields, low quality agricultural products, deteriorating soil fertility, contributing to water pollution, and consequently threatening human and animal life. This review gives an insight into the toxicological effects of the herbicide glyphosate and current approaches to track and identify trace amounts of this agrochemical along with its biodegradability and possible remediating strategies. Efforts have also been made to summarize the biodegradation mechanisms and catabolic enzymes involved in glyphosate metabolism.
- 1 February 2020
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 46  (2) , 329-342
Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design
Objective: The purpose of present research was to develop and statistically optimize nitrendipine nanoemulsion gel for transdermal delivery using box-behnken statistical design. Method: The nanoemulsion formulations bearing nitrendipine were prepared by application of ternary phase diagram and spontaneous emulsification method. Box-behnken design was employed for the optimization of nitrendipine loaded nanoemulsion. The independent variables were oil, surfactant and co-surfactant while globule size, drug content and zeta potential were dependent variables. The optimized nanoemulsion formulation was incorporated into gel and evaluated for in-vitro release, ex-vivo permeation studies, confocal laser scanning microscopy, skin irritation and histopathological studies. Results: The optimized formulation through box-behnken statistical design showed globule size of 20.43 ± 1.50 nm, drug content of 97.05 ± 1.77% and zeta potential of -15.45 ± 0.35 mV. The ex-vivo study confirmed the enhanced delivery of nitrendipine from nanoemulsion gel than compare to drug solution by virtue of better permeation and solubility. Nanoemulsion gel was proved significantly superior by confocal laser scanning microscopy for satisfactory permeation and distribution of gel, deep into the rat skin. The optimized gel was found with no allergic dermal effects and was proved safe by histopathological studies for transdermal application. Conclusions: Results reveals that developed nitrendipine nanoemulsion gel overcomes the limitation of low penetration and accentuate permeation through albino Wistar rat skin. It was concluded that nanoemulsion gel could be utilized as a potential carrier for transdermal delivery of nitrendipine.
- 1 February 2020
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 46  (2) , 329-342
Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design
Objective: The purpose of present research was to develop and statistically optimize nitrendipine nanoemulsion gel for transdermal delivery using box-behnken statistical design. Method: The nanoemulsion formulations bearing nitrendipine were prepared by application of ternary phase diagram and spontaneous emulsification method. Box-behnken design was employed for the optimization of nitrendipine loaded nanoemulsion. The independent variables were oil, surfactant and co-surfactant while globule size, drug content and zeta potential were dependent variables. The optimized nanoemulsion formulation was incorporated into gel and evaluated for in-vitro release, ex-vivo permeation studies, confocal laser scanning microscopy, skin irritation and histopathological studies. Results: The optimized formulation through box-behnken statistical design showed globule size of 20.43 ± 1.50 nm, drug content of 97.05 ± 1.77% and zeta potential of -15.45 ± 0.35 mV. The ex-vivo study confirmed the enhanced delivery of nitrendipine from nanoemulsion gel than compare to drug solution by virtue of better permeation and solubility. Nanoemulsion gel was proved significantly superior by confocal laser scanning microscopy for satisfactory permeation and distribution of gel, deep into the rat skin. The optimized gel was found with no allergic dermal effects and was proved safe by histopathological studies for transdermal application. Conclusions: Results reveals that developed nitrendipine nanoemulsion gel overcomes the limitation of low penetration and accentuate permeation through albino Wistar rat skin. It was concluded that nanoemulsion gel could be utilized as a potential carrier for transdermal delivery of nitrendipine.
- Open Access
- 6 January 2020
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 16  (1) , 73-91
Quality by Design Approach for Development and Characterisation of Solid Lipid Nanoparticles of Quetiapine Fumarate
Background: Quetiapine fumarate, a 2nd generation anti-psychotic drug has oral bioavailability of 9% because of hepatic first pass metabolism. Reports suggest that co-administration of drugs with lipids affects their absorption pathways, enhances lymphatic transport thus bypassing hepatic first-pass metabolism resulting in enhanced bioavailability.Objective: The present work aimed at developing, and characterising potentially lymphatic absorbable Solid Lipid Nanoparticles (SLN) of quetiapine fumarate by Quality by Design approach.Method: Hot emulsification followed by ultrasonication was used as a method of preparation. Precirol ATO5, Phospholipon 90G and Poloxamer 188 were used as a lipid, stabilizer and surfactant respectively. A32 Central Composite design optimised the 2 independent variables, lipid concentration and stabilizer concentration and assessed their effect on percent Entrapment Efficiency (%EE: Y1). The lyophilized SLNs were studied for stability at 5 ±3οC and 25 ± 2οC/60 ± 5% RH for 3 months.Results: The optimised formula derived for SLN had 270mg Precirol ATO5 and 107mg of Phospholipon 90G giving %EE of 76.53%. Mean particle size was 159.8nm with polydispersity index 0.273 and zeta potential -6.6mV. In-vitro drug release followed Korsmeyer-Peppas kinetics (R2=0.917) with release exponent n=0.722 indicating non-Fickian diffusion. Transmission electron microscopy images exhibited particles to be spherical and smooth. Fourier-transform infrared spectroscopy, differential scanning calorimetry and X-ray diffraction studies ascertained drug-excipient compatibility. Stability studies suggested 5οC as appropriate temperature for storage and preserving important characteristics within acceptable limits.Conclusion: Development and optimisation by Quality by Design were justified as it yielded SLN having acceptable characteristics and potential application for intestinal lymphatic transport.
- 6 January 2020
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 16  (1) , 73-91
Open AccessQuality by Design Approach for Development and Characterisation of Solid Lipid Nanoparticles of Quetiapine Fumarate
Background: Quetiapine fumarate, a 2nd generation anti-psychotic drug has oral bioavailability of 9% because of hepatic first pass metabolism. Reports suggest that co-administration of drugs with lipids affects their absorption pathways, enhances lymphatic transport thus bypassing hepatic first-pass metabolism resulting in enhanced bioavailability.Objective: The present work aimed at developing, and characterising potentially lymphatic absorbable Solid Lipid Nanoparticles (SLN) of quetiapine fumarate by Quality by Design approach.Method: Hot emulsification followed by ultrasonication was used as a method of preparation. Precirol ATO5, Phospholipon 90G and Poloxamer 188 were used as a lipid, stabilizer and surfactant respectively. A32 Central Composite design optimised the 2 independent variables, lipid concentration and stabilizer concentration and assessed their effect on percent Entrapment Efficiency (%EE: Y1). The lyophilized SLNs were studied for stability at 5 ±3οC and 25 ± 2οC/60 ± 5% RH for 3 months.Results: The optimised formula derived for SLN had 270mg Precirol ATO5 and 107mg of Phospholipon 90G giving %EE of 76.53%. Mean particle size was 159.8nm with polydispersity index 0.273 and zeta potential -6.6mV. In-vitro drug release followed Korsmeyer-Peppas kinetics (R2=0.917) with release exponent n=0.722 indicating non-Fickian diffusion. Transmission electron microscopy images exhibited particles to be spherical and smooth. Fourier-transform infrared spectroscopy, differential scanning calorimetry and X-ray diffraction studies ascertained drug-excipient compatibility. Stability studies suggested 5οC as appropriate temperature for storage and preserving important characteristics within acceptable limits.Conclusion: Development and optimisation by Quality by Design were justified as it yielded SLN having acceptable characteristics and potential application for intestinal lymphatic transport.
- 19 November 2019
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 9  (2) , 47-52
Investigative Study on Impact of Solid: Liquid Lipid Ratio and Stabilizer Amount on Some Characteristics of Nanostructure Lipid Carriers of Quetiapine Fumarate
Aim: Nanostrucured Lipid Carriers (NLCs) are the 2nd generation of Solid Lipid Nanoparticles (SLNs) designed to overcome limitations of SLNs. Their characteristics can be modulated by variations in formulation and process variables. The present study was aimed at investigating the influence of formulation variables, solid: liquid lipid ratio and stabilizer amount on some important characteristics of Quetiapine Fumarate Nanostructured Lipid Carriers (QF-NLC) like percent Entrapment Efficiency (%EE), Particle Size (PS), Polydispersity Index (PDI) and Zeta Potential (ZP). Methods and Materials: The study was carried out by varying the ratio of solid:liquid lipid and stabilizer amount sequentially in two sets of experiments and studying their impact on the selected characteristics of QF-NLC. Hot emulsification followed by ultrasonication was the method of preparation. Precirol ATO5, oleic acid and Phospholipon 90G (P90G) were selected as the solid lipid, liquid lipid and stabilizer respectively. Results: On varying the solid: liquid lipid ratios in the first set of experiments, %EE, PS and ZP ranged from 65.05-75.52%, 281.5-150.4nm and -16.4- -21.4mV respectively showing that decrease in the ratio was related to %EE and ZP inversely and to PS and PDI directly. Increase in the amount of P90G in the second set of experiments showed %EE to be affected positively and PS and PDI negatively. ZP was less sensitive to changes in P90G. Conclusion: From the study it can be concluded that by varying the chosen formulation variables a QF-NLC formulation with desired characteristics can be formulated for the chosen objective.
- 19 November 2019
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 9  (2) , 47-52
Investigative Study on Impact of Solid: Liquid Lipid Ratio and Stabilizer Amount on Some Characteristics of Nanostructure Lipid Carriers of Quetiapine Fumarate
Aim: Nanostrucured Lipid Carriers (NLCs) are the 2nd generation of Solid Lipid Nanoparticles (SLNs) designed to overcome limitations of SLNs. Their characteristics can be modulated by variations in formulation and process variables. The present study was aimed at investigating the influence of formulation variables, solid: liquid lipid ratio and stabilizer amount on some important characteristics of Quetiapine Fumarate Nanostructured Lipid Carriers (QF-NLC) like percent Entrapment Efficiency (%EE), Particle Size (PS), Polydispersity Index (PDI) and Zeta Potential (ZP). Methods and Materials: The study was carried out by varying the ratio of solid:liquid lipid and stabilizer amount sequentially in two sets of experiments and studying their impact on the selected characteristics of QF-NLC. Hot emulsification followed by ultrasonication was the method of preparation. Precirol ATO5, oleic acid and Phospholipon 90G (P90G) were selected as the solid lipid, liquid lipid and stabilizer respectively. Results: On varying the solid: liquid lipid ratios in the first set of experiments, %EE, PS and ZP ranged from 65.05-75.52%, 281.5-150.4nm and -16.4- -21.4mV respectively showing that decrease in the ratio was related to %EE and ZP inversely and to PS and PDI directly. Increase in the amount of P90G in the second set of experiments showed %EE to be affected positively and PS and PDI negatively. ZP was less sensitive to changes in P90G. Conclusion: From the study it can be concluded that by varying the chosen formulation variables a QF-NLC formulation with desired characteristics can be formulated for the chosen objective.
- Open Access
- 2 September 2019
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 165-170
FORMULATION AND EVALUATION OF LYCOPENE LOADED COLLOIDAL MICROPARTICLES GEL
Objective: The objective of the present investigation was to design and evaluate a gel containing lycopene loaded colloidal microparticles. Methods: The lycopene loaded colloidal microparticles were successfully prepared by Cloud point technique to form colloids using Tween 40 and Tween 60 surfactant solution and then incorporated into microparticles by solvent evaporation method using polymer like HPMC and ethyl cellulose. These colloidal microparticles were evaluated for particle size (PS), drug loading (DL), entrapment efficiency (EE), Scanning Electron Microscopy (SEM). Further, these colloidal microparticles were incorporated into a topical formulation i.e., gel. This topical formulation was then evaluated for macroscopic examination, viscosity, drug content, spreadability, antioxidant activity, in vitro permeation and release kinetics. Results: Colloidal microparticles were successfully prepared and the particle size, drug loading and entrapment efficiency were found to be 249.45±14.2 μm, 49.8±0.96 % and 93.4±0.26 % respectively. FTIR study depicted no chemical interaction between pure drug lycopene and other excipients. The topical formulation showed sustained release and followed Korsmeyer-Peppas release kinetics model. Conclusion: The sustained release topical formulation of lycopene was successfully prepared using Tween 40 and Tween 60 surfactant solution and combination of HPMC and ethyl cellulose and evaluated for several parameters.
- 2 September 2019
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 165-170
Open AccessFORMULATION AND EVALUATION OF LYCOPENE LOADED COLLOIDAL MICROPARTICLES GEL
Objective: The objective of the present investigation was to design and evaluate a gel containing lycopene loaded colloidal microparticles. Methods: The lycopene loaded colloidal microparticles were successfully prepared by Cloud point technique to form colloids using Tween 40 and Tween 60 surfactant solution and then incorporated into microparticles by solvent evaporation method using polymer like HPMC and ethyl cellulose. These colloidal microparticles were evaluated for particle size (PS), drug loading (DL), entrapment efficiency (EE), Scanning Electron Microscopy (SEM). Further, these colloidal microparticles were incorporated into a topical formulation i.e., gel. This topical formulation was then evaluated for macroscopic examination, viscosity, drug content, spreadability, antioxidant activity, in vitro permeation and release kinetics. Results: Colloidal microparticles were successfully prepared and the particle size, drug loading and entrapment efficiency were found to be 249.45±14.2 μm, 49.8±0.96 % and 93.4±0.26 % respectively. FTIR study depicted no chemical interaction between pure drug lycopene and other excipients. The topical formulation showed sustained release and followed Korsmeyer-Peppas release kinetics model. Conclusion: The sustained release topical formulation of lycopene was successfully prepared using Tween 40 and Tween 60 surfactant solution and combination of HPMC and ethyl cellulose and evaluated for several parameters.
- 1 October 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 381, 91
Possible role of ATP-sensitive potassium and MPTP channels in pharmacological postconditioning in mouse brain
- 1 October 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 381, 91
Possible role of ATP-sensitive potassium and MPTP channels in pharmacological postconditioning in mouse brain
- Open Access
- 15 September 2014
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 4  (5) , 21-28
NANOTECHNOLOGY IN NOVEL DRUG DELIVERY SYSTEM
Nanotechnology is novel and having full scope of contribution in the field of human health care. Recent advances suggest that nanotechnology will have a profound impact on diseases prevention, diagnosis and treatment. It will allow faster drug absorption, controlled dose release with minimized side-effects. Nanotechnology plays a crucial role in revolutionizing the field of surgery, detection of disease like cancer. Drugs with high toxic potential can be given with a better safety profile with the utility of nanotechnology. It is an ideal targeting system should have long circulating time, it should be present at appropriate Concentrations at the target site, and it should not lose its activity or therapeutic efficacy while in circulation. Our aim is to review the potential applications and various drug delivery system of nanotechnology. Keywords: Nanotechnology, health care, side-effects, revolutionizing, concentrations.
- 15 September 2014
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 4  (5) , 21-28
Open AccessNANOTECHNOLOGY IN NOVEL DRUG DELIVERY SYSTEM
Nanotechnology is novel and having full scope of contribution in the field of human health care. Recent advances suggest that nanotechnology will have a profound impact on diseases prevention, diagnosis and treatment. It will allow faster drug absorption, controlled dose release with minimized side-effects. Nanotechnology plays a crucial role in revolutionizing the field of surgery, detection of disease like cancer. Drugs with high toxic potential can be given with a better safety profile with the utility of nanotechnology. It is an ideal targeting system should have long circulating time, it should be present at appropriate Concentrations at the target site, and it should not lose its activity or therapeutic efficacy while in circulation. Our aim is to review the potential applications and various drug delivery system of nanotechnology. Keywords: Nanotechnology, health care, side-effects, revolutionizing, concentrations.
- Open Access
- 15 September 2014
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 4  (5) , 48-54
MUCOADHESIVE MICROSPHERES: A REVIEW
Carrier technology provides an interesting as well as an intelligent approach for the delivery of drug. It offers delivery of drug by coupling the drug to a carrier particle such as microspheres, mucoadhesive microspheres nanoparticles, liposomes, etc. Mucoadhesive microspheres constitute an important part of this particulate drug delivery system because of their small size and other efficient properties. Mucoadhesive microspheres plays a vital role in the novel drug delivery system. Some drug delivery problems are overcome by producing controlled drug delivery system which enhances the therapeutic efficacy of a drug. From various approaches one approach is to using mucoadhesive microsphere as a carrier system for drug delivery. Mucoadhesive microspheres exhibit a prolonged residence time at the site of application or absorption and facilitate an intimate contact with the underlying absorption surface and thus contribute to improved and better therapeutic performance of drugs and also mucoadhesive microspheres have advantages like efficient absorption and enhanced bioavailability of the drugs due to a high surface to volume ratio, a much more intimate contact with the mucus layer,controlled and sustained release of drug from dosage form and specific targeting of drugs to the absorption site. Mucoadhesive microspheres have been developed for oral, buccal, nasal, ocular, rectal and vaginal for either systemic or local effects. It is an ideal targeting system with high safty profile. This review article gives the information about mucoadhesion and theories of mucoadhesion. It also contains a number of available methods of preparation of mucoadhesive microspheres. Keywords: Mucoadhesion, mucoadhesive microspheres,mucoadhesive polymers,application.
- 15 September 2014
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 4  (5) , 48-54
Open AccessMUCOADHESIVE MICROSPHERES: A REVIEW
Carrier technology provides an interesting as well as an intelligent approach for the delivery of drug. It offers delivery of drug by coupling the drug to a carrier particle such as microspheres, mucoadhesive microspheres nanoparticles, liposomes, etc. Mucoadhesive microspheres constitute an important part of this particulate drug delivery system because of their small size and other efficient properties. Mucoadhesive microspheres plays a vital role in the novel drug delivery system. Some drug delivery problems are overcome by producing controlled drug delivery system which enhances the therapeutic efficacy of a drug. From various approaches one approach is to using mucoadhesive microsphere as a carrier system for drug delivery. Mucoadhesive microspheres exhibit a prolonged residence time at the site of application or absorption and facilitate an intimate contact with the underlying absorption surface and thus contribute to improved and better therapeutic performance of drugs and also mucoadhesive microspheres have advantages like efficient absorption and enhanced bioavailability of the drugs due to a high surface to volume ratio, a much more intimate contact with the mucus layer,controlled and sustained release of drug from dosage form and specific targeting of drugs to the absorption site. Mucoadhesive microspheres have been developed for oral, buccal, nasal, ocular, rectal and vaginal for either systemic or local effects. It is an ideal targeting system with high safty profile. This review article gives the information about mucoadhesion and theories of mucoadhesion. It also contains a number of available methods of preparation of mucoadhesive microspheres. Keywords: Mucoadhesion, mucoadhesive microspheres,mucoadhesive polymers,application.
- Open Access
- 15 May 2014
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 4  (3) , 45-51
SYNERGISTIC ACTION OF PENETRATION ENHANCERS IN TRANSDERMAL DRUG DELIVERY
Transdermal drug delivery system is a desirable form of drug delivery because of the obvious advantages over other routes of delivery. One promising challenge in designing transdermal drug delivery system is to overcome the natural transport barrier of the skin i.e. the stratum corneum which is the rate limiting step in percutaneous absorption of drugs. Various penetration enhancers are now being used alone or in combinations to enhance the penetration of the drug through the skin. The main objective of the present study is to review the synergistic action of various penetration enhancers on the efficacy and safety of the drug. It has been found from the literature study that systems employing synergistic mixtures of penetration enhancers offer superior skin permeation enhancement as compared to those employing single penetration enhancer. Various chemical, physical and carrier approaches have also been reviewed to increase skin permeation of the drug. Keywords: Transdermal, penetration enhancers, synergistic mixtures, permeation enhancement.
- 15 May 2014
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 4  (3) , 45-51
Open AccessSYNERGISTIC ACTION OF PENETRATION ENHANCERS IN TRANSDERMAL DRUG DELIVERY
Transdermal drug delivery system is a desirable form of drug delivery because of the obvious advantages over other routes of delivery. One promising challenge in designing transdermal drug delivery system is to overcome the natural transport barrier of the skin i.e. the stratum corneum which is the rate limiting step in percutaneous absorption of drugs. Various penetration enhancers are now being used alone or in combinations to enhance the penetration of the drug through the skin. The main objective of the present study is to review the synergistic action of various penetration enhancers on the efficacy and safety of the drug. It has been found from the literature study that systems employing synergistic mixtures of penetration enhancers offer superior skin permeation enhancement as compared to those employing single penetration enhancer. Various chemical, physical and carrier approaches have also been reviewed to increase skin permeation of the drug. Keywords: Transdermal, penetration enhancers, synergistic mixtures, permeation enhancement.